Project Grant K23AI182452
Award Date
9/11/24
Completion Date
8/31/29
Dollars Obligated
$169K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $204,347 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Vermont & State Agricultural College. The funding supports a 2-year research project to study the intracellular colonization strategies of Salmonella enterica serovar Typhimurium within human intestinal epithelial cells and macrophages. The researchers will use a combination of bacterial fluorescent...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is for the development of a direct diagnostic test for infectious and congenital syphilis. The $260,760 award to the University of Victoria aims to create a test that: (1) exhibits high sensitivity and specificity at all disease stages; (2) can differentiate active versus past infections; (3) can differentiate syphilis from yaws;...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $142,932 to The Trustees of Columbia University in the City of New York to investigate the use of wastewater surveillance data to improve forecasting of SARS-CoV-2 transmission dynamics. The project aims to evaluate whether incorporating wastewater data can enhance the accuracy of predictive models for COVID-19 cases...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $126,096 to the University of California, San Diego (UCSD) to conduct research aimed at elucidating the mechanisms governing microbial competition in the gut during Salmonella Typhimurium (STM) infection. The primary goals are to identify potential STM competitors within the gut microbiota and investigate the role of...
This federal Project Grant award, identified as R01AI189569, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award totaling $531,245.00 will fund research at Yale University focused on the structural and functional characterization of the sorting platform, a key component of the type III secretion system (T3SS) in Salmonella bacteria. Through a multidisciplinary approach involving...
This $100,000 Project Grant award from the National Science Foundation (NSF) Social, Behavioral, and Economic Sciences (SBE) program (CFDA 47.075) aims to integrate wastewater surveillance and human behavior data to enhance epidemiological modeling and outbreak detection. The principal investigators at Lawrence Technological University will pursue three main objectives: (1) developing an early-warning system using wastewater and digital/social behavior data, (2) creating a...
The University of California, Davis received a $225,839 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, titled "Vaccine Induction of Salmonella-Specific Th1 Memory Cells," aims to investigate the role of tissue-resident memory CD4 T cells in providing protection against systemic Salmonella infections, and to evaluate the use of an mRNA nanoparticle vaccine...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $239,366 to The Leland Stanford Junior University to evaluate the causal effects of anti-malarial chemoprevention in pregnancy and childhood on growth outcomes. The study aims to (1) assess the impact of intermittent preventative treatments in pregnancy (IPTp) and childhood (IPTc) on child growth, and (2) investigate...
This federal Project Grant award, valued at $771,690.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate syphilis pathogenesis through genetic engineering of the syphilis-causing bacteria Treponema pallidum. The award aims to leverage new capabilities to genetically manipulate T. pallidum in order to better understand the role of antigenic variation in the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $206,251 to Duke University to conduct research on the molecular mechanism and pathophysiology of robust STAT3 signaling during oral Salmonella Typhimurium infection. The research aims to elucidate how the Salmonella effector protein SARA hijacks and prolongs host STAT3 signaling to promote anti-inflammatory...